Navigation Links
Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market
Date:11/9/2007

BIRMINGHAM, Ala. and EXTON, Pa., Nov. 9 /PRNewswire-USNewswire/ -- Southern Research Institute and Absorption Systems, LP today announced that they have expanded their joint marketing agreement to allow Absorption Systems to represent Southern Research in European biotechnology and pharmaceutical markets. Ten months ago, the two organizations announced that they had signed a joint marketing agreement to collaborate in marketing contract research services in the areas of toxicology and bioanalytical services to biotechnology and pharmaceutical clients in the U.S.

The agreement expands this partnership so Absorption Systems will provide marketing and sales representation of Southern Research in Europe. Both companies will continue to provide critical preclinical contract research support to the biotechnology and pharmaceutical industries. Financial terms of the agreement were not announced.

"Our international business has expanded dramatically in the past 18 months, so this agreement with Absorption Systems will allow us to enhance our support to those clients, while continuing to expand our geographic reach," said Chaarles G. Fogelgren, director of Business Operations for the Drug Development Division at Southern Research.

"We are excited about expanding our relationship with Southern Research. Adding their capabilities in toxicology, cancer efficacy and anti-infectives to our capabilities in ADME and bioanalysis will provide a better outsourcing solution for our clients," said Patrick Dentinger, president and CEO of Absorption Systems.

The European sales and marketing representation also signals an expansion of Southern Research's dedicated sales force. In the past year, Southern Research has established a U.S.-based geographic sales force (http://www.southernresearch.org/bd-territories.html) and is moving to expand upon this success.

About A
'/>"/>

SOURCE Southern Research Institute
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Biomaxx Systems Inc. Selected as Technical Consultant By Southern Cross Agricultural Developments
2. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
3. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
6. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
7. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
8. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
9. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
10. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
11. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... , October 24, 2014 ... Markets ( http://www.researchandmarkets.com/research/t5t5pd/the_global_market ) has announced the addition ... Nanotubes, Graphene And Other 2-D Nanomaterials " ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,CNTs and graphene are ... known to man, with a performance-per-weight greater ...
(Date:10/22/2014)... , Oct. 22, 2014  Actavis plc (NYSE: ... and Rhythm, a biopharmaceutical company, today announced that Actavis ... wholly owned subsidiary, Rhythm Health, Inc., which is developing ... of diabetic gastroparesis and other GI functional disorders. ... trial of relamorelin for the treatment of diabetic gastroparesis ...
(Date:10/22/2014)... Md. (PRWEB) October 21, 2014 Shimadzu ... an LC/MS/MS data tool for the pain management and ... of data processing and review by allowing users to ... to clinicians. , QuantAnalytics allows analysts to filter ... This expedites data processing by eliminating the need to ...
(Date:10/22/2014)... 22, 2014 Currently offering a ... & D Weighing, Rice Lake, and Ohaus, Pipette.com ... . The Sartorius CPA Semi-Micro Balance is ideal ... precise, and user-friendly laboratory balance. , Sartorius is ... their laboratory balances are well known for their ...
Breaking Biology Technology:The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 2The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 3The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3
... at the National Institute of Standards and Technology (NIST) ... viscosity measurementscritical data for a wide variety of fields ... as small as a few nanoliters. Currently a table-top ... tool for biotechnologists studying minute quantities of complex materials ...
... Mr. Robert Nealon reports: IGEN Networks Corp. ... Standard and Poor,s ("S&P") has approved IGEN for their ... Records is considered the premier source for information on ... professionals. As part of the approval, IGEN,s corporate profile ...
... of Services in Neuronal Research Using Human iPS... -- YOKOHAMA, Japan, September 1, 2010 ... ... --> ... var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
Cached Biology Technology:Micro rheometer is latest Lab On a Chip device 2IGEN Networks Corp. obtains Blue Sky Statutory Compliance in 38 States with Approval of Standard & Poor's 2ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 2ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 3ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 4ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 5ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 6
(Date:10/18/2014)... undiagnosed, suspected genetic conditions, a certain type of exome ... yield than traditional molecular diagnostic methods, according to a ... being released to coincide with the American Society of ... the protein­coding region of the genome (the complete set ... or organism), has been rapidly applied in research settings ...
(Date:10/16/2014)... body. Battles are won, lost or sometimes end ... as tumor dormancy—can last up to 25 years ... poorly understood. , A new computational model ... Professor of Chemistry at Princeton University, may help ... switch to a malignant state. Published today in ...
(Date:10/16/2014)... infections and worldwide claims the lives of 160,000 ... University have succeeded in developing a promising vaccination ... , Xavier Saelens (VIB/UGent): "We discovered a new ... development of a novel approach to vaccination against ... small children and elderly people." , RSV: ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Modeling tumor dormancy 2New perspectives for development of an RSV vaccine 2
... 3, 2010 Genes interact in complex networks that govern ... relationships. Researchers are now discovering how biological networks change ... today in Genome Research ( www.genome.org ), scientists ... light on how interactions go awry in disease. MicroRNAs ...
... Researchers from the University of Leeds, UK, the ... for Molecular Medicine (MDC) in Berlin, Germany, have ... Their studies have identified how ,junk, DNA promotes the ... Professor Constanze Bonifer (University of Leeds) and Dr Stephan ...
... oil could help prevent ulcerative colitis, according to a new ... Anglia (UEA). Presented today at the Digestive Disease ... with a diet rich in oleic acid which is ... ulcerative colitis. Oleic acid is a monounsaturated fatty acid found ...
Cached Biology News:MicroRNA network study implicates rewired interactions in cancer 2'Junk DNA' drives cancer growth 2Olive oil could guard against developing ulcerative colitis 2
... Maximize the value of your ... We offer the support you need ... using the most up to date ... with the Gene Expression Profiling Service ...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ...
Formula variant: With macro- and micronutrients. Physical Form: powder Suitab tst: plant cell culture tested...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ...
Biology Products: